Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2823783 | Multiple Sclerosis and Related Disorders | 2016 | 4 Pages |
Abstract
We provide evidence that supports the validity of GLTEQ scores as measures of vigorous and MVPA in POMS. Researchers and clinicians might adopt this scale for measuring PA.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Dominique Kinnett-Hopkins, Stephanie A. Grover, E. Ann Yeh, Robert W. Motl,